Opinion|Videos|October 7, 2024
Care Coordination for High-Risk CRM Patients
Key Takeaways
- Future guidelines may integrate emerging evidence and novel therapeutic strategies for CKD, T2D, and CVD management.
- Personalized treatment plans considering the interplay between CKD, T2D, and CVD could be emphasized.
Medical experts examine strategies for care coordination in high-risk patients with cardiometabolic conditions.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How do you define effective care coordination in the context of high-risk CRM patients?
- What are the key elements of a successful care coordination program for these patients?
- Why is this so challenging at the large health systems represented here and around the country?
This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.
Advertisement
Related to this article
Upper-extremity synovial sarcoma required more staged surgery, while lower-extremity disease carried more complications and metastases.
In the US alone, 1.1 million individuals are living with the progressive neurodegenerative movement disorder, and 90,000 are diagnosed each year.
The National Comprehensive Cancer Network update on mantle cell lymphoma puts covalent BTK inhibitors, MRD testing, and TP53 sequencing at the center of frontline care, while adding pirtobrutinib and a pair of CAR T-cell therapies for disease that progresses on a BTK inhibitor.
CDC's David A. Siegel, MD, MPH, on rising cancer diagnoses, falling deaths, and where CDC's cancer control resources go next.
CDC's Jane Henley, MSPH, explains what's behind falling lung cancer deaths and why 4 in 5 eligible adults still aren't getting screened.
Machine learning identified age, BMI, income, and reproductive factors as key predictors of overactive bladder risk among US women.
Tammy Lundstrom, MD, JD, discusses the new childhood vaccine order, single-dose MMR access concerns, and the measles resurgence.
Advertisement
Advertisement